Angiotensin ii acetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for angiotensin ii acetate and what is the scope of patent protection?
Angiotensin ii acetate
is the generic ingredient in one branded drug marketed by La Jolla Pharma and is included in one NDA. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.Angiotensin ii acetate has thirty-seven patent family members in twenty-one countries.
One supplier is listed for this compound.
Summary for angiotensin ii acetate
| International Patents: | 37 |
| US Patents: | 10 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 23 |
| Clinical Trials: | 5 |
| Patent Applications: | 51 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | angiotensin ii acetate at DailyMed |
Recent Clinical Trials for angiotensin ii acetate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| American Lung Association | Phase 2 |
| Johns Hopkins University | Phase 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
Pharmacology for angiotensin ii acetate
| Drug Class | Vasoconstrictor |
| Physiological Effect | Vasoconstriction |
Medical Subject Heading (MeSH) Categories for angiotensin ii acetate
Anatomical Therapeutic Chemical (ATC) Classes for angiotensin ii acetate
Paragraph IV (Patent) Challenges for ANGIOTENSIN II ACETATE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| GIAPREZA | Injection | angiotensin ii acetate | 2.5 mg/mL | 209360 | 1 | 2021-12-21 |
US Patents and Regulatory Information for angiotensin ii acetate
International Patents for angiotensin ii acetate
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Slovenia | 2986308 | See Plans and Pricing | |
| Japan | 2017501154 | 低血圧治療のための単独または併用使用されるアンギオテンシンＩＩ | See Plans and Pricing |
| Poland | 2986308 | See Plans and Pricing | |
| Croatia | P20200009 | See Plans and Pricing | |
| Australia | 2017205168 | Methods for administering angiotensin II | See Plans and Pricing |
| China | 111920939 | 血管紧张素II单独或以组合方式用于治疗低血压 (Angiotensin ll alone or in combination for the treatment of hypotension) | See Plans and Pricing |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2022 - 2023
NCE-1 Patent Challenge Dates 2022 - 2023
ClinicalTrialExchange - Connecting volunteers and trials
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
